drugset / Trial / NCT01720056

Verapamil vs Steroid to Prevent Keloid Recurrence

NCT01720056

Phase 4 Terminated 14 enrolled The University of Western Australia
RandomizedParallel-groupDouble-blindPrevention

Summary

Keloid scarring is a severe cosmetic and painful disease of the skin. The gold standard treatment is yet to be clarified. This randomized clinical pilot study will compare the effects of two local treatments for preventing keloid recurrence after surgical removal; steroid and verapamil. Study hypothesis: Intralesional therapy with the calcium antagonist verapamil has equal treatment efficacy as steroid injection.

Timeline

Start
2012-10
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Kenalog 10 Unknown 10 mg/ml Subcutaneous
Comparator Verapamil Other / unclassified 2.5 mg/ml Subcutaneous

Indications